» Articles » PMID: 39459561

and Counts, Virulence Gene Profile, Antimicrobial Resistance, and Biofilm Formation Capacity During Pig Slaughter Stages

Abstract

This study aimed to count and in different locations on pig carcasses (shank, loin, abdomen, shoulder, and jowl) from two slaughterhouses (A and B) between September 2019 and July 2021 during different slaughter stages (after bleeding, after passing through the epilator machine, after manual toileting in the dirty area, before and after evisceration, and after the final washing), as well as verify antimicrobial resistance and biofilm formation capacity. The main points of and contamination were identified in the two slaughterhouses through three collections. The stages with the highest counts were post-bleeding and evisceration in both slaughterhouses and after manual toileting in slaughterhouse B in the first collection. Most isolates were resistant to multiple antimicrobials, with higher resistance frequencies to amoxicillin, ampicillin, chloramphenicol, sulfonamides, and streptomycin. The virulence genes , , and were also detected. Three isolates had all three genes and exhibited resistance to at least six antimicrobial classes (β-lactams, macrolides, aminoglycosides, sulfonamides, amphenicols, and quinolones). isolates also showed a high frequency of strains with moderate and strong in vitro biofilm-forming capacity. This is the first study to characterize microbial contamination by pig slaughter stage in the Federal District region, demonstrating the critical points for hygienic production. was isolated from the surface of pig carcasses, as well as the virulence genes , , and were detected. The multi-antimicrobial resistant isolates also had a moderate-to-strong biofilm formation capacity, thus demonstrating risks to public health.

References
1.
Paton A, Paton J . Detection and characterization of Shiga toxigenic Escherichia coli by using multiplex PCR assays for stx1, stx2, eaeA, enterohemorrhagic E. coli hlyA, rfbO111, and rfbO157. J Clin Microbiol. 1998; 36(2):598-602. PMC: 104589. DOI: 10.1128/JCM.36.2.598-602.1998. View

2.
Magiorakos A, Srinivasan A, Carey R, Carmeli Y, Falagas M, Giske C . Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2011; 18(3):268-81. DOI: 10.1111/j.1469-0691.2011.03570.x. View

3.
Djordjevic D, Wiedmann M, McLandsborough L . Microtiter plate assay for assessment of Listeria monocytogenes biofilm formation. Appl Environ Microbiol. 2002; 68(6):2950-8. PMC: 123944. DOI: 10.1128/AEM.68.6.2950-2958.2002. View

4.
Tadesse D, Zhao S, Tong E, Ayers S, Singh A, Bartholomew M . Antimicrobial drug resistance in Escherichia coli from humans and food animals, United States, 1950-2002. Emerg Infect Dis. 2012; 18(5):741-9. PMC: 3358085. DOI: 10.3201/eid1805.111153. View

5.
China B, Pirson V, Mainil J . Typing of bovine attaching and effacing Escherichia coli by multiplex in vitro amplification of virulence-associated genes. Appl Environ Microbiol. 1996; 62(9):3462-5. PMC: 168144. DOI: 10.1128/aem.62.9.3462-3465.1996. View